Literature DB >> 9794485

Monoclonal antibodies specific for rat relaxin. X. Endogenous relaxin induces changes in the histological characteristics of the rat vagina during the second half of pregnancy.

S Zhao1, O D Sherwood.   

Abstract

This study employed morphometric analysis to evaluate changes in the histological characteristics that accompany relaxin-induced growth and softening of the vagina during the second half of rat pregnancy. There were three treatment groups (N = 4/group). Five milligrams of a monoclonal antibody for rat relaxin, designated MCA1, were injected i.v. daily on days 12-21 of gestation to treatment group MCA1. Control groups received either 5 mg of monoclonal antibody for fluorescein (MCAF; monoclonal antibody control) or 0.5 ml PBS (vehicle control). Vaginas were removed on day 22 of pregnancy, fixed in 10% neutral-buffered formalin, and embedded in paraffin. Tissue sections (5 microm) were stained with Gomori's trichrome to visualize collagen, or orcein to visualize elastin. Measurements were performed with a light microscope equipped with a video camera connected to a computer. Within the vaginal stroma, the density of collagen fiber bundles was lower, the length of elastin fibers was shorter, and the cross-sectional area and wall thickness of arteries were greater in relaxin-replete control rats than in relaxin-deficient MCA1-treated rats. These relaxin-induced changes in the stroma appear to account, at least in part, for the hormone's softening effect on the vagina. Within the epithelium, there were approximately 2-fold more basal and mucus-secreting cells in relaxin-replete control rats than in MCA1-treated rats. The relaxin-induced accumulation of epithelial cells appears to contribute to vaginal growth. We conclude that relaxin plays a role in preparing the vagina as well as the cervix for rapid and safe delivery in pregnant rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794485     DOI: 10.1210/endo.139.11.6327

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  New Insights into biological roles of relaxin and relaxin-related peptides.

Authors:  Jae-Il Park; Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 2.  Relaxin: antifibrotic properties and effects in models of disease.

Authors:  Chrishan S Samuel
Journal:  Clin Med Res       Date:  2005-11

3.  Pregnancy-induced adaptations in intramuscular extracellular matrix of rat pelvic floor muscles.

Authors:  Marianna Alperin; Timothy Kaddis; Rajeswari Pichika; Mary C Esparza; Richard L Lieber
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

4.  Conditional deletion of the relaxin receptor gene in cells of smooth muscle lineage affects lower reproductive tract in pregnant mice.

Authors:  Elena M Kaftanovskaya; Zaohua Huang; Carolina Lopez; Kirk Conrad; Alexander I Agoulnik
Journal:  Biol Reprod       Date:  2015-02-25       Impact factor: 4.285

5.  Relaxin decreases the severity of established hepatic fibrosis in mice.

Authors:  Robert G Bennett; Dean G Heimann; Sudhir Singh; Ronda L Simpson; Dean J Tuma
Journal:  Liver Int       Date:  2013-07-21       Impact factor: 5.828

6.  Relaxin acts on stromal cells to promote epithelial and stromal proliferation and inhibit apoptosis in the mouse cervix and vagina.

Authors:  LiJuan Yao; Alexander I Agoulnik; Paul S Cooke; Daryl D Meling; O David Sherwood
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.